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Recent studies (1) on 8-Methoxypsoralen
("Xanthotoxin", "Methoxsalen" or "8-1\'IOP")
have created interest in chemical agents which
augment the skin pigmentation of normal as well
as vitiligenous persons. The photosensitization
elicited by these substances has focused attention
on the mechanism of this phenomenon (2, 3). In
the presence of long-wave ultraviolet radiation,
many of these psoralen derivatives, which are
generally known as furocoumarins, evoke changes
on mammalian skin manifested by erythema and
increased pigmentation. Furthermore, these
substances inhibit a number of enzymes both
in vice and in vitro (4). Musaj o and associates
(5, 6) have investigated the photosensitizing
activity of various furocoumarins following
topical application of 25 ,.ig/cm2 on human skin.
Their studies have shown that psoralen was the
most active of the naturally occurring furoeou-
marins. In earlier communicntions of this series
Pathak and Fitzpatrick (7, 8) confirmed these
observations and reported the photosensitizing
activity of a number of substituted psoralens.
Substitution with mcthoxy-, nitro-, amino-, or
hydroxy-at 5 or 8 positions resulted in partial or
complete loss of the photoscnsitizing response of
the parent psoralcn. Likewise, hydrogenation at
4', 5' resulted in complete loss of activity. It
was also shown that coumarin derivatives were
inactive. Finally, it was demonstrated that a
linear fusion of furan and coumarin rings, as in
the psoralen molecule, was essential for this
response; a non-linear structure like isopsoralcn
had no photosensitizing action.
Quite recently Musajo et ci. (9) reported similar
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t The term photodynamic action has been used
by several workers including us. As defined by
Blum (12) it implies an oxygen obligate photo-
sensitization of living systems. Fowlks vi ci (3)
and our own observations have shown that the
action of psoralens is not oxygen dependent; hence
we now prefer to call this light-induced biological
change as photosensitization.
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studies on the relationship between chemical
constitution and the photodynamic properties in
the furocoumarin series. They concluded that
the furocoumarin nucleus was essential for
activity and that introduction of a methyl group
reduces the photodynamic action; the reduction
being slight for substitution in the 4, 4' and 5'
positions but marked in the 3 position. 4'-
Phenyl substitution was shown by these ivorkers
to result in an inactive product.
This paper reports an extension of our investi-
gation of the relationship between molecular
configuration and the erythematous activity of
various synthetic furocoumarins following ul-
traviolet irradiation. This study also covers the
effect of methyl and higher alkyl substitution, the
effect of hydrogenating the furan ring, and the
activities of several non-furocoumarin compounds
including many coumarins.
MATERIALS AND METHODS
The method of testing the photosensitizing
activity of these synthetically prepared deriva-
tives has been given in detail in an earlier com-
munication (5). Briefly the method consists of
fixing an adhesive tape (25 x 7.5 cm) containing
ten square "windows" each 2.5 cm2, on the back
of smoothly depilated albino guinea-pigs. Various
amounts usually ranging from 25 jig to 500 jig per
2.5 em2 skin area were applied topically in different
windows. Dilutions for each compound are made
in such a way that the desired amount is obtained
in 0.1 to 0.2 ml of ethanol. Two standard solutions
of psoralen and 8-methoxypsoralen (25 jxg/0.l ml)
are also applied in two separate windows each time
along with the compound under test. Thirty to
forty-five minutes after application, the hack of
the test animal is irradiated at a fixed distance
from a standard long-wave ultraviolet light for
forty-five minutes. At the end of 18 hours and 36
honrs, the animal is examined for the presence of
erythema. Visible intensity of erythema is re-
corded in conventional + or — signs as shown
below and also with Photovolt photoelectric
reflection meter model 610 operated on A.C.
power line equipped with green tristimulus filter
as described by Daniels vi at (10). The reflectance
of adjacent control area is also measured. The per
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cent reflectance difference between control area
and the test area measures the iotensity of
erythemal response. The erythemal response with
red filter was also recorded for each area under
test, but the readings showed little correlation
with the intensity of erythema and hence have not
been presented in tables I and II.
Sign
No erythema, normal
skin
Just perceptible cry-
thema detected by
tenderness of skin
Definite erythema of low
intensity, pink color
++ Pink red erythema
--++ Markedly red erythema
++++Deep red, blistering,
oedema, etc.
Most of the compounds used in this study were
prepared synthetically by one of us (KDK) with
other collaborators and the syntheses will be
reported elsewhere. Some were synthesized ac-
cording to known procedures for which references
are given in the bibhngraphy (14, 15, 16). A few
were obtained from sources indicated in the
acknowledgements.
Ultraviolet light source. All investigations re-
ported in the present studies were carried out with
long-wave ultraviolet light > 3200 A. The black
light unit model 70 GIn Craft, 250 watt, has been
described earlier (8). The lamp emits approxi-
mately 6 x 10 ergs/cm5/min. The animal was
kept supine on a wooden board between 12 to 15
cm. away from the lamp, and the light projected
perpendicularly from above.
In the evaluation of erythemal responsc, the
following variables which can cnusc errors have to
be carefully controlled to obtain reproducible
responses:(a) Guinea pig skin should be undamaged,
without scratches, quite smooth. The animal
should be housed individually in separate cage,
preferably in rooms without bright light. (b) No
projecting hair should be seen on the entire back
of the animal when test compounds are being
applied. (c) The hair should be removed by the
aid of clipper and mild depilatory and skin cleaned
thoroughly by warm water. Shaving with safety
razor is to be avoided. (d) It is always essential to
check the visible intensity of erythema and the
reflection readings simultaneously. For each test
area the reflection readings from the adjacent
control area should be recorded.
RESULTS
In Tablc I, all of the compounds which pro-
duced an erythemal response are listed, as closely
as possible, in the order of decreasing response.
Their activities are tabulated in terms of percepti-
ble erythema (visible intensity) and the pbotovolt
reflection meter readings with a green tristim-
ulus filter. These readings represent per cent
reflectance difference between the test area and
the adjacent control area.
In Table II, the compounds which produced
no erythema are listed, and each entry is followed
by the concentrations in pg/2.5 cm2 skin area
applied topically for which observations were
made.
Effect of group substitution on biological activity:
Methyl substitution either at thc 4, 5' or 8
positions does not alter the activity of the
psoralen molecule. 4-Methylpsoralcn, 5' ,8-
dimethyl psoralen and 4,5', S-trimethyl psoralen
were found to be as photosensitizing as psoralen,
(Table I * 1, 2, 3, 4). But methyl substitution
at the 4' position results in considerable loss of
activity. 4, 4'-Dimcthyl psoralen was signifi-
cantly less active than psoralen. (Table I, * 11).
Likewise methyl substitution at the 3 position
(3, 4, 5', 8- tetramethyl psoralen) mitigates
the erythemal response (Table I, * 10). Several
other 3-substituted psoralens, 3 ,4-bcnzo-5'
,
8-
dimethylpsoralen, 3 ,4-cyclohcxeno-5' ,S-dime-
thylpsoralen, and 3-n-butyl-4 ,5',S-trimethyl
psoralen, also showed diminished activity
(Table I,*14, 15, 16).
Wben the S-methyl group of the very active
4,5', S-trimethylpsoralcn is replaced by an n-
propyl substituent, to give 4, 5'-dimethyl-S-n-
propyl psoralen, the photosensitizing activity
drops markedly, possibly due to the effect of the
longer alkyl chain on the solnbility of the psoralen
molecule (Table I, * 7). Likewise 5' isopropyl
substituted anhydromarmesin (Table I, * 17)
exhibited a weak response. All of the psoralens
bearing one or more non alkyl substituents (e.g.
aeetamido, acetyl, amino, bromo, methoxy or
nitro) were less active than psoralen itself (Table
I, *6, 8, 12, 13). As reported earlier (7, 8),
5-Methoxypsoralen (Table I, S 5) like 5-math-
oxypsoralen, was less active than psoralen. In
analogy with the effect of hydroxy substitution
Erythemal Response Relative Activity
Inactive
Weakly active
Definitely
active
Quite active
Very active
Highest possi-
ble response
TABLE II
Purocournarins and coumarins e.chibiting no photosensitizing activity
applied topi-No. Compound Structure cafly per 2.5 cm2
skin area
38. 8-amino-4, 5'-dimethylpsoralen NH2 50, 100, 250,H3 C0 /00 500, 1000
CH2
39. 4',5'-dihydro-8-methoxy- OCH3 50, 100, 250,
psoralen 500, 1000
112
40. 4',5'-dihydro-4-methyl- 0 0 0 so, ioo, 250,
psoralen
:
500, 1000
Cl3
41. 3,5-dibromo-4',5'-dihydro-8- OCH3 50, 100, 250,
methoxypsoraleti
112 0/ j/O\,0 500
H2
I Br
42. 5-bromo-8-rnethoxypsoralen OCH3 100, 200, 250,/0 /0 0 500, 1000
43. 4',S'-dihydro-S-ethylcarharnyl- OCH3 so, ioo, 200,
8-methoxypsoralen
/0\O/0\/0
250500
0= 0 CH2CH3
44. , 7-dimethyl-6-hydroxy-5- C113 25, 50, 100, 200,
acrylic acid, /()\/0\,0 500,
45. 6-hydroxy-f3,2,7-trirnethyl-5- C113 25, 50,100,200,
acrylic acid, CH3\/O\/O\/o 250,500,
KTh
C113
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TABLE TI—Continued
/3, 7-dimethyl-2-isopropyl-6-
hydroxy-5-benzoxazole acrylic
acid, ô-lactone
2, 6-dihydroxy-/3, 7-dimethyl-5-
benzoxazoleacrylic acid,
-lactone
4', 5'-dihydro-4, 5'-dimethyl-
isopsoralen
f3,2-dimethyl-5-hydroxy-4 (or 6)
benzofuran acrylic acid,
ô-lactone
3, 2-dimethyl-5-hydroxy-4-
benzoxazoleacrylic acid
ô-lactone
8-acetyl-7-allyloxy-4-methyl-
coumarin
0
CH,
g. applied topi-
cally per 2.5 cm'
skin area
50, 100, 200,
250, 500,
1000
25, 50, 100, 200,
250, 500,
1000
50, 100, 250,
500, 1000
50, 100, 250
500, 1000
50, 100, 200,
250, 500
1000
100, 250, 500,
1000
No. Compound Structure
H,C
H3C/NO
0113
OH,
HOoo0
H3
H, C
46.
47.
48.
49.
50.
51.
/Oy0
HaCJ/ H,
or
0
0L3J
H3Ci/ H,
0
/0 \/O \/
CH,
1120
Hc
H,
176
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TABLE IT—Continued
No. Compound Structure
ug. applied topi-
cally per 2.5 cm2
skin area
52. 7-allyloxy-4-methyl-8-n-propyl- C1120H2—CH3 100, 250, 500,
\5/C
0 1000coumarin /0
112 C
H
H2( 6113
53. 7-allyloxy-3,4-cyclohexeno-8- CH3 100, 250, 500,0 1000methylcoumarin /0/ /0\/
1120
H
H2 H2)H2
H2
54. 8-acetoxy-7-allyleoumarin 100, 200, 250,
500, 10000—C--OH3
Cl2 0\/0/HO
113 C
55. 7-allyl-8-hydroxycoumarin OH 100, 200, 500,
OH2 0\/0 1000/HC
H2
56. 7-acetoxy-8-allylcoumarin 0112—011=0112 100, 200, 250,
500
0=0
H3
57. 7,8-diacetoxy-4-methylcou- 0 50, 200, 250,
mann o—---cH, 500/0 \/\/00=C
H3
H3
58. 7-acetoxy-8-(2',3'-dibromo- Br Br 200, 250, 500,
propyl) -4-methylcoumarin CH2—H—H2 1000
/00=C
113
TABLE TI—Continued
Mg. applied topi-
No. Compound Structure rally per 2.5 cm'
skin area
59. 7-acetoxy-6-allyl-8-diacetyl- 0 0 100, 200, 250,
amino-4-methylcoumariri 1 500CH3—C—N—C—CH3
CH3—C--0 I 0N
o /LU
CH2=CH—CH2
60. 8-acetamido-7-acetoxy-6-aIIyl- 0 50, 100, 250,o
HN—---CH3 5004-methylcoumarin
CH3—C--0 0
N- //N/
CH2===CH—C02
61. 7-acetoxy-6-allyl-3,4-cyclo- OH3 50, 100, 250,CH3—C—0 0 500, 1000hexeno-8-methylcoumarin \ . /0
CH2=CH—CH2
H2L)H2
H3
62. 7-acetoxy-3,4-cyclohexeno-6- CH3 100, 250, 500
(2',3'-dibromo propyl)-8- CHCCO .1. /0 0N
methylcoumarin 0
CH2—CH—-CH2
Br Br H2
63. 8-acetyl-6 allyl-7-hydroxy-4- 0=0—OH3 50, 200, 250,
methylcoumarin HO 500
N
CH2=CH—CH2
64. 6-allyl-7-hydroxy-3,4,8-tri- OH3 100, 200, 250,
methylcoumarin HO 0 500, 1000
CH3=CH—CH3 CH,
OH3
65. 8-acetarnido-6-allyl-7-hydroxy- 0 100, 200, 250,
NH—C—OH34-methylcoumarin 500, 1000
HO /0 0
CH3==CH—CH2
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66. 8-allyl-7-hydroxy-4-methyl-
coumarin
67. 7-hydroxy-3, 4, 8-trimethyl-
coumarin
70. 3, 4-cyclohexeno-7-hydroxy-8-
methylcoumarin
72. 8-acetamido-7-hydroxy-4-
methylcoumarin
CH2—CH=CH2
HO I 0\ /Oy
CH,
HO o o
CH,
CH,
c=O
HO 0Nv/ \
/
ÔH,
CH3
pg. applied topi-
cally per 2.5 cm'
skio area
100, 200, 250,
500
250, 500, 1000
No. Compound
TABLE IT—Continued
Structuce
68. 8-acetyl-6-(2',3'-dibromo-
propyl) -7-hyclroxy-4-methyl-
coumarin
69. 7-hydroxy-8-methylconmarin-3-
carboxylic acid HO
Br Br
H, H•CH2'
71.
100, 200, 250,
500. 1000
100, 200, 500,
1000
50, 200, 250,
500, 1000
100, 250, 500
100, 200, 250,
500, 1000
8-arnino-7-hydroxy-4-methyl-
roimlarin
CH3
0
L/k
CH3
HO 0\</O
H,)H2
HO
0
NH—-—CH3
HObOO
CH3
0
179
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TABLE IT—Continued
5-acetoxy-4-methyl-5-nitro
coumarin
0
H3CO—CH2—O 0
H,C—C
OH,0
• O/)
NO2 CII,
O—C----C5H,
Br Br
I CII,—CH--CII,
O—C—CH,
O—C—C,II,
I CII,,—CII=CH,
O—C—CII,
0
eg. applied topi-
cally per 2.5cm'
skin area
100, 200, 250,
500, 1000
reported earlier (7), 8-amino substitution (Table
II, #38) completely eliminated activity.
Effect of hydrogenation at the 4' and 5' positions:
Hydrogenation of the 4', 5' double bond
resulted in almost complete loss of activity.
4' - 5' - dihydro - 8 - methoxypsoralen, 4' - 5' -
dihydro- 4 -methylpsoralen, 4', 5' -dihydro - 5 -
ethyl - earbamyl- 8 - methoxypsoralen and 3, 5 -
dibromo - 4',5' - dihydro - 8 - methoxypsoralen
were completely inactive (Table II, #39,
40, 43, 41). 3 - Bromo - 4' - 5' - dihydro - 8 -
methoxypsoralen showed a very weak response
(Table I, #22).
Effect of substitution at 3 and 4 positions: Sub-
No. Compoood Steocture
73. Methyl, 6-aeetyl-4-methyl-7-
coumarinoxyaeetate
74.
75. 2-acetoxy-5-benzoyloxy (2'-3'-
dibromopropyl) -benzene
76. 4-aeetoxy-3-allylphenylbenzoate
77. 4, 8-dimethyl-7-hydroxyeoumarin HO
78. 7-acetoxy-6-allyl-4-methyl-8-n-
propylcoumarin
200, 250, 500,
1000
100, 250, 500
100, 250, 500
50, 100, 200,
500
100, 250, 500,
1000
CII, o0\// NIil]
CII,
0
CII, CII, CII,CII,— 0o/'(CII,—CII CII,
CII,
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stitutions at 3 and 4 positions showed marked
loss of the photosensitizing action. 3,4,5',8-
tetramethyl psoralen; 3n-hntyl 4,5', 8-trimethyl
psoralen; 3 ,4-benzo-5' ,8-dimethylpsoralen and
3, 4-cyclohexeno-5' , 8-dimethyipsoralen exhibited
weak responses (Table I, #10, 16, 14, 15).
Activity of Oxazolocoumarins: Five oxazolo-
coumarins (compounds #44—47, 50, Table II)
were tested. Although these compounds are quite
similar in strnctnre to the furocoumarins, they
were all completely inactive.
Activity of difuran derivatives: As shown in
Table I, #9, 2,6,8 - trimethyl benzo -
(1,2-b ,5,4-b') difuran induced a characteristic
+ + grade erythema. This compound was avail-
able only in a crude form and it is likely that it
will show much greater photosensitizing action
when purified. This observation indicates that
substantial photosensitizing activity is not con-
fined to the furocoumarin nucleus as stated by
Musajo et at. (9). Also 5, 6-dihydro-6-(a-hydroxy-
isopropyl) benzo-(1 ,2-b,5,4-b') difuran-2-ear-
boxylic acid and marmesin (Table I, # 18, 20)
showed a weak erythemal response. It appears
that a linear tricyclie system of benzene and furan
rings also possesses photosensitizing ability.
Hydrogenation of furan ring at the 5 and 6 posi-
tions resulted in considerable loss of activity,
(Table I, #20,23).
Non-tinear furocoumarin compounds: Non-
linear furocoumarins were essentially inactive.
4'-S'-Dihydro, 4, 5'-dimethyl-isopsoralen (Table
II, #48) was inactive. Seslin, a non-linear chro-
manocoumarin, produced a weak response. 5'-
methyl isopsoralen showed just a trace of cry-
themal response, (Table I, #21, 19). Compound
#49, Table II, showed no photosensitizing action.
Studies with coumarin derivatives: Most of the
coumarin derivates tested were inactive. Those
that were active (compounds #24 to 37, Table I)
gave only a weak response even at high concen-
trations. Compounds 30, 32, 33 are very possibly
converted to furocoumarins in vivo. The activity
of these 14 coumarin derivatives out of 42 is sig-
nificantly less than other active furocoumarins
reported in Table I. Six compounds with an
allyloxy group in the 7 position (24, 25, 26, 27, 28,
29) showed weak but definite activity. Interest-
ingly, p-allyloxy phenol (#31, Table I) showed a
definite response. Substitution of methyl, higher
alkyl, allyl, hydroxy, nitro, acetyl or acetoxy
groups on the coumarin ring did not produce
active compounds (Table II, #51—78). But the
fact that a few coumarin derivatives do elicit
photosensitized responses suggests that the
furocoumarin structure is not essential for photo-
sensitizing action.
nlseussloN
It is the aim in any study such as this, to relate
the structure of the compound to its biological
activity. What is hoped for ideally, is the
emergence of a common denominator of structure
or functional group relationship which will pro-
vide clues into the mechanism of biological
activity or chemical reactivity. Surprisingly,
however, no such definitive relationship is forth-
coming in our series. An important variant which
has not been controlled in these studies is that of
solubility of the test material in the physiological
milieu in which biological activity has been tested.
Differences in solubility and permeability within
the cellular environment can modify and alter the
response. However, notwithstanding this limita-
tion of our approach, certain common factors do
emerge from these experiments. For example,
methylation at carbon atoms 4, 5' and 8 of the
psoralen nucleus does not markedly modify the
biological response, but methylation at the 4'
position does reduce the activity. Likewise meth-
ylation at the 3 position also results in loss of
activity.
Examination of the data reveals that molecules
possessing linear trieyelie systems like psoralen
are generally active but nonlinear structures such
as isopsoralen are inactive. Substitution with
groups which may be designated as electron en-
riching (such as methoxy, amino, acetamido, etc.)
as well as electron withdrawing (such as nitro
and aeeto) imparts a partial or complete loss in
erythemal response. Hydrogenation of the 4', 5'
double bond or substitution of a nitrogen atom
for one of the carbon atoms in the furan ring
eliminates activity. Indeed any substitution
which markedly alters the resonance within the
psoralen system mitigates or destroys the
activity.
This is not unexpected from our other experi-
ence. We recently showed (11) that almost all
compounds of tlus series which are biologically
active and induce photosensitization, possess
absorption and fluorescent peaks in the range of
320—360 mu/420—460 mu, respectively, while those
which were inactive lie outside these narrow limits.
The significance of this observation is underlined
by the fact that the long wave ultraviolet (>
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3200 A) light has been found to potentiate pso-
ralen action (erythema and sun tanning). The
augmentation of this response by the active pso-
ralens is probably in large measure a result of the
capture of radiation energy of this wavelength re-
gion (320—360 mu). Thereby it is evident, that al-
teration of the molecule with groups which alter
the absorption and fluorescent spectra, decreases
the biological response. This response pivots pri-
marily on the photoactivation of psoralen. The ab-
sorption of light at a specific wavelength and the
emergence of light energy at another from a com-
ponent in intimate contact with sensitive cellular
structures has been conceived as crucial for photo-
sensitizing activity (3, 13). Evidently, any devia-
tion from the character of this absorption will
alter the capacity of the molecule to exhibit its
photosensitized biological response.
suMMARy
This study covers the biological photosensi-
tizing action of 36 furocoumarin and 42 eoumarin
derivatives. The appearance of erythemal re-
sponse following topical application and ultra-
violet irradiation with wavelengths greater than
3200 A indicated the photosensitizing activity of
these compounds. None of the compounds tested
was more active than psoralen itself. Substitution
with methyl groups at positions 4, 5', and 8 did
not reduce the activity but methyl substitution
at the 4' or 3 positions significantly decreased the
photosensitizing activity of psoralen. Simulta-
neous substitution at 3 and 4 positions also re-
sulted in loss of activity. Substitution of an alkyl
group larger than methyl decreased the activity.
Substitution with methoxy, amino, nitro, acetyl,
acetamino, bromo, ethylcarbamyl at the 5 or 8
positions resulted in either partial or complete
loss of activity. Oxazolocoumarin derivatives
were found to be inactive. Hydrogenation of the
4', 5' double bond practically eliminates the
photosensitizing response. Compounds possessing
the isopsoralen structure showed no activity. A
benzodifuran derivative was found to be active
but hydrogenation resulted in loss of activity.
Most of the coumarin derivatives were inactive
but six allyloxy coumarins showed a weak photo-
sensitizing response. The implications of these
findings in terms of the relationship between
molecular configuration and the erythematous
activity are discussed.
ACKNOWLEnGEMENT5
The authors wish to express their sincere ap-
preciation to Dr. Thomas B. Fitzpatrick and Dr.
Farrington Daniels, Jr., for their interest and en-
couragement in these investigations.
The synthetic studies were made possible by
grants from the Paul B. Elder Company, Bryan,
Ohio, and the Upjohn Company, Kalamazoo,
Michigan. Several of the compounds were pre-
pared as part of a synthetic program under a
grant from the National Science Foundation
(NSF-G 5795). The biological testing studies were
aided by grants from the United States Public
Health Service, No. CY-2837 (C2 and C3) PET
and B 1572 (C-151).
We arc greatly indebted for some of the com-
pounds used in this study to Dr. R. B. Moffett,
the Upjohn Company, Kalamazoo, Michigan;
Paul B. Elder Company, Bryan, Ohio; Sandoz,
Ltd., Basel, Switzerland; Dr. B. E. Christensen,
Oregon State College, Corvallis, Oregon, Dr. A.
Chatterjie, University College of Science, Cal-
cutta, India, and Dr. M. B. E. Fayes, National
Research Center, U. A. R. Cairo, Egypt.
REFERENCES
1. Psoralens and radiant energy; proceedings of
a symposium. J. Invest. Dermat., 32: 131—
391, 1959.
2. FowLxs, W. L., GEIFFITH, D. C. AND OorNsKY,E. L.: Photosensitization of bacteria by
furocoumarins and related substances.
Nature, 181: 571, 1958.
3. OmNsicy, E. L., GREEN, C. S., GRIFFITH, B.
C. AND FowLKs, W. L.: Lethal photosensi-
tization of bacteria with 5-Methoxypsoralon
to longwave ultraviolet radiation. J. Baet.,
78: 1959.
4. PATHAK, NI. A. AND FowLKs, W. L.: In Press.
5. Mus.&Jo, E. L., RODIGHIERO, C. AND CAP0-
BALE, C.: L'aetivite photodynamique des
coumarines naturelles. Bull. Soc. chim. biol.,
36: 1213, 1954.
6. MO5AJO, L.: Intersanti poprieta della furo-
coumariue naturali, Il-Farmaeo, X (No. 5),
1, 1955.
7. PATEAK M. A. AND FITzPATRIcK, T. B.: Re-
lationship of molecular configuration to the
activity of furocoumarins. J. Invest.
Dermat., 32: 255, 1959.
8. PATEAK, M. A. AND FITzPATRICK. T. B.: Bio-
assay of natural and synthetic furoeou-
marins (psoralens). J. Invest. Dermat., 32:
509, 1959.
9. Musjo, L., RonIGnIERo, C., CAPORALE, C.
AND ANTONELLO, C.: Relation between
constitution and photodynamie properties
of furoeoumarins. Farmaco (Pavia), Ed.
Sri., 13: 355, 1958.
ERYTHEMAL ACTIVITY OF FTJROCOUMARINS 183
10. Diacs, F., JR. AND IMBuE, J. J). Corn-
panson between visual gradiDg and re-
flectance measurements of erytbema pro-
duced by sunlight. J. Invest. Dermat., 30:
295, 1958.
11. PATHAK, M. A. AND FELLMAN, J. H.:
Activating and fluorescent wave -Ieugths of
furocoumarins: psoralens. Nature. In Press.
12. BLUIG, H. F.: Photodynamic action and dis-
eases caused by light. Reinhold Publication
Corporation, New York, N. Y., 1941.
13. Fowi.xs, W. L.: The mechanism of the photo-
dynamic effect. J. Invest. Dermat., 32:233,
1959.
14. LIMAYE, B. B. AND GANGAL, I). IL: Syntheses
in the furocoumarin group. III. Formation
of the linear 3, 4'-dimethyl-7', 6'-furocou-
mann. Rasavanam, 1: 15—23, 1936.
15. BROKKE, M. B. AND CHRIsTENSEN, B. B.:
Certain reactions of xanthotoxin, J. Org.
Chem., 23: 589, 1958.
16. HORNING, B. C. AND REI5NER, B. B.: Syn-
thesis of psoralen and related furocou-
marins. J. Am. Chem. Soc. 72: 1514, 1950.
